46 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
if a majority of our Common Shares are held in the United States and we fail to meet the additional requirements necessary to avoid loss of foreign private … issuer status, such as if: (i) a majority of our directors or executive officers are U.S. citizens or residents; (ii) a majority of our assets
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:13pm
by the affirmative vote of a majority of the votes cast in respect thereof by Shareholders present in person or by proxy at the Meeting. In the absence
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
if a majority of our Common Shares are held in the United States and we fail to meet the additional requirements necessary to avoid loss of foreign private … issuer status, such as if: (i) a majority of our directors or executive officers are U.S. citizens or residents; (ii) a majority of our assets
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:08pm
by the affirmative vote of a majority of the votes cast in respect thereof by Shareholders present in person or by proxy at the Meeting. In the absence
424B5
olz05m
29 Nov 23
Prospectus supplement for primary offering
9:57pm
6-K
EX-99.1
mdr 3876h0
27 Oct 23
XORTX Announces Results of Special Meeting of Shareholders
6:05pm
6-K
EX-99.2
f9j4b7uc476s4x
4 Oct 23
Notice of Special Meeting of Shareholders
7:00am
424B3
xunqgk
14 Aug 23
Prospectus supplement
4:42pm
424B3
fsqnh12l 4d
14 Aug 23
Prospectus supplement
4:40pm
POS AM
xj1h5qz40jn6u3rl7t14
4 Aug 23
Prospectus update (post-effective amendment)
4:08pm
POS AM
35zmobev3gvjsq99yk56
4 Aug 23
Prospectus update (post-effective amendment)
4:05pm
6-K
EX-99.2
4sfp n5l1hxre33uo
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
6-K
EX-99.3
945xah8j pczgc4
3 Apr 23
Consolidated Financial Statements
6:05am
S-8
EX-4.2
a98zum6qtwdhr8 b7
27 Oct 22
Registration of securities for employees
7:09pm
6-K
EX-99.1
27z2nf6c6zlla5ecl71
7 Oct 22
Current report (foreign)
4:30pm
424B4
a1p ko178789o8t1
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
v8vczjaou0
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm